Metabolic control and chronic complications during a 3-year follow-up period in a cohort of type 2 diabetic patients attended in primary care in the Community of Madrid (Spain)

被引:1
作者
Arrieta, Francisco [1 ,2 ]
Pinera, Marbella [3 ]
Iglesias, Pedro [1 ,2 ]
Nogales, Pedro [3 ]
Angel Salinero-Fort, Miguel [4 ]
Carlos Abanades, Juan [5 ]
Ignacio Botella-Carretero, Jose [1 ,2 ]
Calanas, Alfonso [1 ]
Antonio Balsa, Jose [1 ,2 ]
Zamarron, Isabel [1 ,2 ]
Rovira, Adela [6 ]
Vazquez, Clotilde [1 ,2 ]
机构
[1] Hosp Ramon & Cajal, Dept Endocrinol & Nutr, Unit Clin Nutr & Obes, E-28034 Madrid, Spain
[2] IRYCIS, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain
[3] Ctr Salud, Med Familia, Madrid, Spain
[4] Hosp Carlos III, Serv Madrileno Salud, Fdn Invest Biomed, Madrid, Spain
[5] Comunidad Madrid, Gerencia Invest & Docencia Atenc Primaria, Madrid, Spain
[6] Hosp Fdn Jimenez Diaz Capio, Madrid, Spain
来源
ENDOCRINOLOGIA Y NUTRICION | 2014年 / 61卷 / 01期
关键词
Type; 2; diabetes; Incidence; Chronic complications; Primary care; Metabolic control; GLYCEMIC CONTROL; RISK-FACTORS; HYPERGLYCEMIA; ASSOCIATION; PREVALENCE; MORTALITY; MELLITUS; REVERSAL;
D O I
10.1016/j.endoen.2013.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Our aim was to analyze both metabolic control and chronic complications of type 2 diabetes mellitus (T2D) patients regularly attended in primary care during a 3 years of follow-up in the Community of Madrid (Spain). Methods: From 2007 to 2010 we prospectively included 3268 patients with T2D attended by 153 primary care physicians from 51 family health centers. An prospective cohort study with annual evaluation over 3 years to the same population was performed. We measured the goals of control in diabetic patients and the incidence of chronic complications of diabetes during the study period. Results: A significant decrease in serum glucose levels (143 +/- 42 mg/dl vs 137 +/- 43 mg/dl, p<0.00), HbA1c (7.09 +/- 1.2% vs 7.02 +/- 1.2%, p<0.00), total cholesterol (191.4 +/- 38 mg/dl vs 181.5 36 mg/dl, p<0.00), LDL cholesterol (114.7 +/- 31 mg/dl vs 105.5 30 mg/dl, p<0.00) and triglyceride levels (144.5 +/- 93 mg/dl vs 138 +/- 84 mg/dl, p<0.00) during study period was documented. On the contrary, a significant elevation in HDL cholesterol levels was observed (49.2 +/- 14 mg/dl vs 49.9 16 mg/dl, p< 0.00). The incidence of diabetic complications throughout the study period was low, with a incidence of coronary heart disease of 6.2%, peripheral arterial disease 3%, ischemic stroke 2.8%, diabetic foot 11.2%, nephropathy 5.9%, retinopathy 4.5%, and neuropathy 3%. Conclusion: Metabolic control in T2D patients attended in primary care in the Community of Madrid throughout 3 years is adequate and is accompanied by low percent of chronic diabetic complications during this period of follow-up. (C) 2013 SEEN. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 28 条
  • [1] Control of Risk Factors for Cardiovascular Disease Among Adults with Previously Diagnosed Type 2 Diabetes Mellitus: A Descriptive Study from a Middle Eastern Arab Population
    Al-Lawati, Jawad A.
    Barakat, Mohammed N.
    Al-Zakwani, Ibrahim
    Elsayed, Medhat K.
    Al-Maskari, Masoud
    Al-Lawati, Nawar M.
    Mohammed, Ali Jaffer
    [J]. OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2012, 6 : 133 - 140
  • [2] [Anonymous], WORLD HLTH STAT 2011
  • [3] [Anonymous], 2010, ENDOCRINOL NUTR
  • [4] Arrieta F, 2011, AV DIABETOL, V27, P53
  • [5] Heart disease in diabetic patients
    Mihaela C. Blendea
    Samy I. McFarlane
    Esma R. Isenovic
    Gregory Gick
    James R. Sowers
    [J]. Current Diabetes Reports, 2003, 3 (3) : 223 - 229
  • [6] High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes
    Boonman-de Winter, L. J. M.
    Rutten, F. H.
    Cramer, M. J. M.
    Landman, M. J.
    Liem, A. H.
    Rutten, G. E. H. M.
    Hoes, A. W.
    [J]. DIABETOLOGIA, 2012, 55 (08) : 2154 - 2162
  • [7] Boussageon R, 2011, BMJ-BRIT MED J, V26, pd4169, DOI DOI 10.1136/BMJ.D4169
  • [8] de Pablos Velasco Pedro, 2009, Endocrinol Nutr, V56, P233, DOI 10.1016/S1575-0922(09)71406-8
  • [9] Del Canizo Gomez Francisco Javier, 2011, Endocrinol Nutr, V58, P163, DOI 10.1016/j.endonu.2011.01.006
  • [10] Fernandez-Miro Merce, 2012, Endocrinol Nutr, V59, P585, DOI 10.1016/j.endonu.2012.08.002